Publications

Randomized, Double-blind, Multi-center, Parallel-group, Evaluation of the Safety and Efficacy of ADAM Zolmitriptan for the Acute Treatment of Migraine ELH Spierings, JL Brandes, DB Kudrow, J Weintraub, J Rubino, DJ Kellerman, SJ Tepper (pdf)

Pharmacokinetics and Tolerability of a New Intracutaneous Microneedle System of Zolmitriptan (ZP-Zolmitriptan) Donald Kellerman, Jason Lickliter, Jacquie Mardell, Thorsten von Stein (pdf)

Randomized, Double-blind, Multi-center, Parallel-group, Evaluation of the Safety and Efficacy of ADAM Zolmitriptan for the Acute Treatment of Migraine. Spierings E, Brandes J, Kudrow D, Weintraub J, Rubino J, Kellerman D, Tepper S. Presented at the 59th Annual Meeting of the American Headache Society (2017).

Differential Active Metabolite Concentration of Zolmitriptan With a New Adhesive Dermally-Applied Microarray (ADAM) System. Schmidt, P. Presented at the 59th Annual Meeting of the American Headache Society (2017).

Pharmacokinetics and tolerability of a New Intracutaneous Microneedle System of Zolmitriptan (ZP-Zolmitriptan). Kellerman D, Lickliter J, Mardell J, Von Stein T. Presented at the 58th Annual Meeting of the American Headache Society  (2016).